| Year |
Citation |
Score |
| 2005 |
Johnston PG, Benson A, Catalano P, Eapen S, Wolmark N, Sargent D, Mc Dermott U, Colangelo L, Wieand S, Goldberg R, Allegra C. The clinical significance of thymidylate synthase (TS) expression in primary colorectal cancer: An Intergroup combined analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3510. PMID 27944396 DOI: 10.1200/Jco.2005.23.16_Suppl.3510 |
0.355 |
|
| 2005 |
Matin K, Jacobs SA, Richards T, Wong MK, Earle M, Evans T, Troetschel M, Ferri W, Friedland D, Pinkerton R, Volkin R, Wieand S, Ramanathan RK. A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer. American Journal of Clinical Oncology. 28: 439-44. PMID 16199980 DOI: 10.1097/01.Coc.0000170797.36351.3A |
0.408 |
|
| 2005 |
Wolmark N, Wieand S, Kuebler PJ, Colangelo L, O'Connell MJ, Yothers G. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07 Journal of Clinical Oncology. 26. DOI: 10.1200/Jco.2005.23.16_Suppl.Lba3500 |
0.379 |
|
| 2004 |
Matin K, Ramanathan RK, Jacobs SA, Wong MK, Earle M, Evans T, Troetschel M, Ferri W, Friedland D, Wieand S. Phase I/II study of trimetrexate (TMTX) and capecitabine (CAP) as second and third- line therapy in patients with advanced colorectal cancer (CRC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3673. PMID 28014622 DOI: 10.1200/Jco.2004.22.14_Suppl.3673 |
0.385 |
|
| 2004 |
Wolmark N, Wieand S, Lembersky B, Colangelo L, Smith R, Pazdur R. A phase III trial comparing oral UFT to FULV in stage II and III carcinoma of the colon: Results of NSABP Protocol C-06 Journal of Clinical Oncology. 22: 3508-3508. DOI: 10.1200/Jco.2004.22.90140.3508 |
0.344 |
|
| 2004 |
Roh MS, Colangelo L, Wieand S, O'Connell M, Petrelli N, Smith R, Mamounas E, Hyams D, Wolmark N. Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum Journal of Clinical Oncology. 22: 3505-3505. DOI: 10.1200/Jco.2004.22.90140.3505 |
0.374 |
|
| 2003 |
Fisher ER, Colangelo L, Wieand S, Fisher B, Wolmark N. Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01. Diseases of the Colon and Rectum. 46: 1021-5; discussion 1. PMID 12907892 DOI: 10.1007/S10350-004-7275-9 |
0.431 |
|
| 2003 |
Jeong JH, Jung SH, Wieand S. A parametric model for long-term follow-up data from phase III breast cancer clinical trials. Statistics in Medicine. 22: 339-52. PMID 12529867 DOI: 10.1002/Sim.1349 |
0.378 |
|
| 2002 |
Kirkwood JM, Richards T, Zarour HM, Sosman J, Ernstoff M, Whiteside TL, Ibrahim J, Blum R, Wieand S, Mascari R. Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690. Cancer. 95: 1101-12. PMID 12209697 DOI: 10.1002/Cncr.10775 |
0.384 |
|
| 2001 |
Wolmark N, Colangelo L, Wieand S. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer Seminars in Oncology. 28: 9-13. PMID 11273592 |
0.358 |
|
| 1999 |
Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham DL, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher ER, Fisher B. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04 Journal of Clinical Oncology. 17: 3553-3559. PMID 10550154 DOI: 10.1200/Jco.1999.17.11.3553 |
0.345 |
|
| 1999 |
Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J, Rockette H. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 1349-55. PMID 10334518 DOI: 10.1200/Jco.1999.17.5.1349 |
0.371 |
|
| 1999 |
Costantino JP, Wieand S. Tamoxifen treatment for breast cancer was associated with an increased risk of endometrial cancer Evidence-Based Obstetrics & Gynecology. 1: 117. DOI: 10.1054/Ebog.1999.0086 |
0.348 |
|
| 1999 |
Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J, Rockette H. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04) Journal of Clinical Oncology. 17: 1349-1355. |
0.343 |
|
| 1998 |
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study Journal of the National Cancer Institute. 90: 1371-1388. PMID 9747868 DOI: 10.1093/Jnci/90.18.1371 |
0.377 |
|
| 1997 |
Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from national surgical adjuvant breast and bowel project B-18 Journal of Clinical Oncology. 15: 2483-2493. PMID 9215816 DOI: 10.1200/Jco.1997.15.7.2483 |
0.353 |
|
| 1992 |
Wieand S, Cha S. Description of the statistical aspects of a study for advanced colorectal cancer patients Statistics in Medicine. 11: 5-11. PMID 1557575 |
0.303 |
|
| Show low-probability matches. |